Chronic pericardial effusion: current concepts and emerging trends.


Journal

Expert review of cardiovascular therapy
ISSN: 1744-8344
Titre abrégé: Expert Rev Cardiovasc Ther
Pays: England
ID NLM: 101182328

Informations de publication

Date de publication:
May 2022
Historique:
pubmed: 7 5 2022
medline: 24 6 2022
entrez: 6 5 2022
Statut: ppublish

Résumé

Pericardial effusion (PEF) is a common and challenging pericardial syndrome with a variety of clinical manifestations ranging from asymptomatic, incidentally uncovered small PEFs, to life-threatening cardiac tamponade. This review focuses on the pathophysiology, epidemiology, aetiology, classification, clinical findings, diagnostic work-up, management, and outcome of PEFs. Particular emphasis has been given on the most recent evidence concerning the contribution of imaging for the detection, differential diagnosis, and evaluation of the haemodynamic impact of PEFs on the diastolic filling of the heart. Moreover, simplified algorithms for PEF triage and management have been included. The management of patients with PEFs is mainly based on four parameters, namely, haemodynamic impact on diastolic function, elevation of inflammatory markers, presence of a specific underlying condition known to be associated with PEF, and finally size and duration of the effusion. Novel data have contributed to change our view towards large, asymptomatic, 'idiopathic' PEFs and dictated a rather conservative approach in most cases. It is also stressed that there is a compelling need for additional research, which is essential for tailored treatments aiming at the improvement of quality of life and containment of health care costs.

Identifiants

pubmed: 35524164
doi: 10.1080/14779072.2022.2075346
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

363-376

Auteurs

George Lazaros (G)

First Department of Cardiology, "Hippokration" Hospital, University of Athens Medical School, Athens, Greece.

Emilia Lazarou (E)

First Department of Cardiology, "Hippokration" Hospital, University of Athens Medical School, Athens, Greece.

Panagiotis Tsioufis (P)

First Department of Cardiology, "Hippokration" Hospital, University of Athens Medical School, Athens, Greece.

Stergios Soulaidopoulos (S)

First Department of Cardiology, "Hippokration" Hospital, University of Athens Medical School, Athens, Greece.

Panagιotis Iliakis (P)

First Department of Cardiology, "Hippokration" Hospital, University of Athens Medical School, Athens, Greece.

Charalambos Vlachopoulos (C)

First Department of Cardiology, "Hippokration" Hospital, University of Athens Medical School, Athens, Greece.

Costas Tsioufis (C)

First Department of Cardiology, "Hippokration" Hospital, University of Athens Medical School, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH